NA
NATCO Pharma Limited
NATCOPHARM.BO · BSE
₹816.95 -0.25% (-₹2.05)
1M -14.40%
Market Cap ₹147.6B
P/E Ratio 12.90x
Div. Yield 0.18%
ROE 13.41%
Bulios Fair Price
₹887.81
8.7% upside
Trenutna cena
₹816.95
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NATCOPHARM.BO trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
81 /100
Cheap EV/EBITDA 10.81x
P/S 4.24x
P/B 1.60x
Growth
93 /100
Growing FCF growth 28.87%
Book val. growth 23.68%
Rev. growth 14.62%
Profitability
99 /100
Strong Net margin 32.84%
Op. margin 24.56%
FCF margin 28.99%
Quality
53 /100
Average ROE 13.41%
ROA 10.33%
Asset turnover 0.31x
Debt
100 /100
Low Current ratio 3.01x
Int. coverage 23.48x
Net debt/EBITDA -0.65x
Stability
25 /100
Unstable Rev. volatility 28.36%
EPS volatility 101.03%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NATCOPHARM.BO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Rajeev Nannapaneni
Employees
4,199
Headquarters
Hyderabad
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report